These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 169168)

  • 21. Streptozotocin diabetogenic action in an experimental neonatal induction model.
    Bequer L; Gómez T; Molina JL; Artiles D; Bermúdez R; Clapés S
    Biomedica; 2016 Jun; 36(2):230-8. PubMed ID: 27622484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fine structure of rat islet cell tumors induced by streptozotocin and nicotinamide.
    Volk BW; Wellmann KF; Brancato P
    Diabetologia; 1974 Feb; 10(1):37-44. PubMed ID: 4365139
    [No Abstract]   [Full Text] [Related]  

  • 23. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
    Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
    J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of diabetogenic drug activity in the rat: 5,5-diphenyl-2-thiohydantoin.
    Mackerer CR; Saunders RN; Haettinger JR; Mehlman MA
    J Toxicol Environ Health; 1977 May; 2(5):1041-51. PubMed ID: 140944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic and morphologic studies in intraportal-islet-transplanted rats.
    Pipeleers-Marichal MA; Pipeleers DG; Cutler J; Lacy PE; Kipnis DM
    Diabetes; 1976 Nov; 25(11):1041-51. PubMed ID: 136376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.
    Masiello P; Cubeddu TL; Frosina G; Bergamini E
    Diabetologia; 1985 Sep; 28(9):683-6. PubMed ID: 2933287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon secretion during the development of insulin-secreting tumors induced by streptozotocin and nicotinamide.
    Yoshino G; Kazumi T; Morita S; Kobayashi N; Terashi K; Baba S
    Endocrinol Jpn; 1979 Dec; 26(6):655-60. PubMed ID: 232037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats.
    Thulesen J; Orskov C; Holst JJ; Poulsen SS
    Endocrinology; 1997 Jan; 138(1):62-8. PubMed ID: 8977386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetogenic effects of n-nitrosomethylurea in the chinese hamster.
    Wilander E; Gunnarsson R
    Acta Pathol Microbiol Scand A; 1975 Mar; 83(2):206-12. PubMed ID: 125026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection by nicotinamide against streptozotocin-induced reduction in pancreatic TRH.
    Kazumi T; Utsumi M; Hirose Y; Ishihara K; Makimura H; Ejiri K; Taniguchi H; Baba S
    Acta Endocrinol (Copenh); 1982 Dec; 101(4):570-3. PubMed ID: 6218725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide.
    Gunnarsson R; Berne C; Hellerström C
    Biochem J; 1974 Jun; 140(3):487-94. PubMed ID: 4374939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidiabetic effect through islet cell protection in streptozotocin diabetes: a preliminary assessment of two thiazolidin-4-ones in Swiss albino mice.
    Kishore A; Nampurath GK; Mathew SP; Zachariah RT; Potu BK; Rao MS; Valiathan M; Chamallamudi MR
    Chem Biol Interact; 2009 Feb; 177(3):242-6. PubMed ID: 19038238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide.
    Masiello P; Broca C; Gross R; Roye M; Manteghetti M; Hillaire-Buys D; Novelli M; Ribes G
    Diabetes; 1998 Feb; 47(2):224-9. PubMed ID: 9519717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term diabetogenic effect of streptozotocin in rats.
    Ar'Rajab A; Ahrén B
    Pancreas; 1993 Jan; 8(1):50-7. PubMed ID: 8419909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of streptozotocin on the pancreatic A cell function.
    Kazumi T; Yoshino G; Morita S; Baba S
    Endocrinol Jpn; 1979 Jun; 26(3):331-5. PubMed ID: 157872
    [No Abstract]   [Full Text] [Related]  

  • 37. Secretory, enzymatic, and morphological characterization of rat pancreatic endocrine tumours induced by streptozotocin and nicotinamide.
    Lenzen S; Klöppel G; Zielmann S; Panten U
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):361-8. PubMed ID: 2992205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):676-84. PubMed ID: 1237421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Streptozotocin treatment of streptozotocin-induced islet cell adenomas in rats.
    Rakieten N; Gordon BS; Beaty A; Bates RW; Schein PS; Standaert FG
    Proc Soc Exp Biol Med; 1976 Mar; 151(3):632-5. PubMed ID: 176670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of severe hyperglycaemia in pregnancy and early overfeeding on islet development and insulin resistance].
    Zeng CJ; Zhang L; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):658-63. PubMed ID: 21092544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.